Dominion Way
Worthing BN14 8SA
United Kingdom
44 1903 844 700
https://www.allergytherapeutics.com
Settore/i: Healthcare
Settore: Drug Manufacturers - Specialty & Generic
Impiegati a tempo pieno: 612
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Manuel Llobet | CEO & Executive Director | 411,98k | N/D | 1965 |
Mr. Shaun Antony Furlong | CFO & Executive Director | N/D | N/D | 1976 |
Ms. Beverly Lees | Group Operations Director | N/D | N/D | N/D |
Dr. Murray Skinner | Chief Scientific Officer | N/D | N/D | N/D |
Mr. Santiago Puig | Business Development Director | N/D | N/D | N/D |
Ms. Sue Baker | Head of Human Resources | N/D | N/D | N/D |
Simon Piggott | Head of Clinical Science | N/D | N/D | N/D |
Alan Bullimore | Head of Communication & Market Development | N/D | N/D | N/D |
Mr. Russell Picket | Group Financial Controller | N/D | N/D | N/D |
Karley Charlotte Mouatt Cheesman | Company Secretary | N/D | N/D | N/D |
Allergy Therapeutics plc, a commercial biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex Quattro, Oralvac, Venomil, Venom ATL Polistes Dominula, Acarovac Plus, Pollinex, Synbiotics, and VLP Peanut. The company develops allergy vaccines for pollen, house dust mites, and animal fur, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally. Allergy Therapeutics plc was incorporated in 2004 and is headquartered in Worthing, the United Kingdom.
L'ISS Governance QualityScore di Allergy Therapeutics plc al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.